Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Mancuso

Showing results (281-290 of 467) with videos related to

Pageof 47
Sort By:
British Journal of Cancer|November 1, 1991
Cathepsin D and epidermal growth factor in human breast cyst fluidG Scambia, P Benedetti Panici, G Ferrandina, et al.
Journal of Endocrinological Investigation|July 1, 1997
The hypothalamic-pituitary-luteal axis in women: effects of long-term orally active opioid antagonist (naltrexone) administrationA M Fulghesu, A Lanzone, R Apa, et al.
Cancer|March 1, 1991
Receptors for epidermal growth factor and steroid hormones in primary laryngeal tumorsG Scambia, P B Panici, F Battaglia, et al.
Oncology|January 1, 1988
Receptors for epidermal growth factor and steroid hormones in human breast cancerF Battaglia, G Polizzi, G Scambia, et al.
Minerva Ginecologica|September 1, 1994
[Treatment in the event of antibiotic prophylaxis failure in gynecologic surgery. A retrospective study of 20 cases]P Paparella, M A Zullo, A L Astorri, et al.
European Journal of Gynaecological Oncology|January 1, 1990
Monitoring ovarian cancer using urine cyclic GMP. A two-centre studyG A Turner, S Greggi, D Guthrie, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|December 1, 1995
Effect of corticotropin-releasing factor on the pituitary-ovary axis in human luteal phaseR Apa, A M Fulghesu, A Lanzone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
nm23 in ovarian cancer: correlation with clinical outcome and other clinicopathologic and biochemical prognostic parametersG Scambia, G Ferrandina, M Marone, et al.
Clinical Endocrinology|July 1, 1996
Evidence of a disturbance of the hypothalamic-pituitary-adrenal axis in polycystic ovary syndrome: effect of naloxoneA Lanzone, M Guido, M Ciampelli, et al.
International Journal of Cancer|August 22, 1997
Altered expression of cyclin D1 and CDK4 genes in ovarian carcinomasV Masciullo, G Scambia, M Marone, et al.
Pageof 47

Showing results (281-290 of 467) with videos related to

Sort By:
Pageof 47
British Journal of Cancer|November 1, 1991
Cathepsin D and epidermal growth factor in human breast cyst fluidG Scambia, P Benedetti Panici, G Ferrandina, et al.
Journal of Endocrinological Investigation|July 1, 1997
The hypothalamic-pituitary-luteal axis in women: effects of long-term orally active opioid antagonist (naltrexone) administrationA M Fulghesu, A Lanzone, R Apa, et al.
Cancer|March 1, 1991
Receptors for epidermal growth factor and steroid hormones in primary laryngeal tumorsG Scambia, P B Panici, F Battaglia, et al.
Oncology|January 1, 1988
Receptors for epidermal growth factor and steroid hormones in human breast cancerF Battaglia, G Polizzi, G Scambia, et al.
Minerva Ginecologica|September 1, 1994
[Treatment in the event of antibiotic prophylaxis failure in gynecologic surgery. A retrospective study of 20 cases]P Paparella, M A Zullo, A L Astorri, et al.
European Journal of Gynaecological Oncology|January 1, 1990
Monitoring ovarian cancer using urine cyclic GMP. A two-centre studyG A Turner, S Greggi, D Guthrie, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|December 1, 1995
Effect of corticotropin-releasing factor on the pituitary-ovary axis in human luteal phaseR Apa, A M Fulghesu, A Lanzone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
nm23 in ovarian cancer: correlation with clinical outcome and other clinicopathologic and biochemical prognostic parametersG Scambia, G Ferrandina, M Marone, et al.
Clinical Endocrinology|July 1, 1996
Evidence of a disturbance of the hypothalamic-pituitary-adrenal axis in polycystic ovary syndrome: effect of naloxoneA Lanzone, M Guido, M Ciampelli, et al.
International Journal of Cancer|August 22, 1997
Altered expression of cyclin D1 and CDK4 genes in ovarian carcinomasV Masciullo, G Scambia, M Marone, et al.
Pageof 47